Found: 11
Select item for more details and to access through your institution.
Analysis of circulating regulatory T cells in patients with metastatic prostate cancer pre- versus post-vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 2, p. 197, doi. 10.1007/s00262-010-0927-9
- By:
- Publication type:
- Article
Immunologic and Prognostic Factors Associated with Overall Survival Employing a Poxviral-based PSA Vaccine in Metastatic Castrate-resistant Prostate Cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 1, doi. 10.1007/s00262-009-0782-8
- By:
- Publication type:
- Article
New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 1, p. 63, doi. 10.1007/s00262-009-0723-6
- By:
- Publication type:
- Article
Propensity for Early Metastatic Spread in Breast Cancer: Role of Tumor Vascularization Features and Tumor Immune Infiltrate.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 5917, doi. 10.3390/cancers13235917
- By:
- Publication type:
- Article
Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4).
- Published in:
- International Journal of Cancer, 2007, v. 121, n. 3, p. 595, doi. 10.1002/ijc.22698
- By:
- Publication type:
- Article
Venous thromboembolism risk prediction in ambulatory cancer patients: Clinical significance of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 5, p. 1234, doi. 10.1002/ijc.29076
- By:
- Publication type:
- Article
Up-regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration-resistant prostate cancer.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 2, p. 373, doi. 10.1002/ijc.28026
- By:
- Publication type:
- Article
Hormonal prostate cancer therapies and cardiovascular disease: a systematic review.
- Published in:
- Heart Failure Reviews, 2022, v. 27, n. 1, p. 119, doi. 10.1007/s10741-020-09984-2
- By:
- Publication type:
- Article
Systemic inflammation, as measured by the neutrophil/lymphocyte ratio, may have differential prognostic impact before and during treatment with fluorouracil, irinotecan and bevacizumab in metastatic colorectal cancer patients.
- Published in:
- Medical Oncology, 2014, v. 31, n. 9, p. 1, doi. 10.1007/s12032-014-0166-6
- By:
- Publication type:
- Article
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B).
- Published in:
- 2013
- By:
- Publication type:
- journal article
Peripheral CD45RO, PD-1, and TLR4 expression in metastatic colorectal cancer patients treated with bevacizumab, fluorouracil, and irinotecan (FOLFIRI-B)
- Published in:
- Medical Oncology, 2013, v. 30, n. 4, p. 1, doi. 10.1007/s12032-013-0743-0
- By:
- Publication type:
- Article